|
1.
|
2023/10
|
論文
|
Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus ANTICANCER RESEARCH 43,pp.4349-4357 （共著）
|
|
2.
|
2023/09
|
論文
|
Impacts of Kampo medicine on induction of CYP3A4 and ABCB1 in gastrointestinal cell model LS180 Journal of Medicinal Herbs 14(2),pp.19-24 （共著）
|
|
3.
|
2021/09
|
論文
|
Induction of Cross-resistance to ABCB1 Substrates in Venetoclax-resistant Human Leukemia HL60 Cells. Anticancer research 41(9),pp.4239-4248 （共著）
|
|
4.
|
2018/09
|
論文
|
同種造血幹細胞移植時に発現する口腔粘膜炎の重症度に影響を与えるリスク因子 日本病院薬剤師会雑誌 54(9),1126-1130頁 （共著）
|
|
5.
|
2018/08
|
論文
|
モノクローナル抗体医薬品による血液に対する有害事象の発症時期ならびに発症パターンに関する調査 医薬品情報学 20(2),72-80頁 （共著）
|
|
6.
|
2017/09
|
論文
|
Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. Annals of transplantation 22,575-580頁 （共著）
|
|
7.
|
2017/07
|
論文
|
Combination of lenalidomide and low-dose dexamethasone therapy promotes the anticoagulant activity of warfarin in patients with immunoglobulin light-chain amyloidosis. Oncology letters 14(1),475-479頁 （共著）
|
|
8.
|
2017/06
|
論文
|
デキサメタゾンの投与量が乳がん患者に対するドセタキセルおよびシクロホスファミド療法の皮膚毒性に及ぼす影響 医療薬学 43(6),313-319頁 （共著）
|
|
9.
|
2016/02
|
論文
|
The interaction between oral melphalan and gastric antisecretory drugs: Impact on clinical efficacy and toxicity. Molecular and clinical oncology 4(2),293-297頁 （共著）
|
|
10.
|
2015/11
|
論文
|
Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor contributes to sunitinib resistance in human renal cell carcinoma cell lines. The Journal of pharmacology and experimental therapeutics 355(2),152-8頁 （共著）
|
|
11.
|
2015/08
|
論文
|
Quantitative interactome analysis reveals a chemoresistant edgotype. Nature communications 6,7928頁 （共著）
|
|
12.
|
2013/02
|
論文
|
Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin. Oncology letters 5(2),427-434頁 （共著）
|
|
13.
|
2013/01
|
論文
|
Effect of dexamethasone on extracellular secretion of cystatin C in cancer cell lines. Biomedical reports 1(1),115-118頁 （共著）
|
|
14.
|
2013/01
|
論文
|
メルファラン連日・大量投与に伴う悪心・嘔吐に対する多剤併用制吐療法の後方視的検討 医療薬学 39(1),18-24頁 （共著）
|
|
15.
|
2012/03
|
論文
|
Differential effects of calcium antagonists on ABCG2/BCRP-mediated drug resistance and transport in SN-38-resistant HeLa cells. Molecular medicine reports 5(3),603-9頁 （共著）
|
|
16.
|
2012/02
|
論文
|
Treatment schedule-dependent effect of 5-fluorouracil and platinum derivatives in colorectal cancer cells. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 45(3),272-81頁 （共著）
|
|
17.
|
2012
|
論文
|
Effects of α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport. PloS one 7(2),e30697頁 （共著）
|
|
18.
|
2011/10
|
論文
|
がん化学療法プロトコル構成薬剤の使用方法に関する標準化への取り組み 日本病院薬剤師会雑誌 47(10),1289-1293頁 （共著）
|
|
19.
|
2011/07
|
論文
|
レナリドミドの薬剤配布プログラムの評価とその課題 日本病院薬剤師会雑誌 47(7),857-861頁 （共著）
|
|
20.
|
2011
|
論文
|
Quantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cells. PloS one 6(5),e19892頁 （共著）
|
|
21.
|
2010/12
|
論文
|
フェンタニルパッチ使用の適正化を目指して 本剤に対する鎮痛耐性が疑われた症例とオピオイド使用量調査 日本緩和医療薬学雑誌 3(3),93-96頁 （共著）
|
|
22.
|
2010/01
|
論文
|
Inhibitory effects of uraemic toxins 3-indoxyl sulfate and p-cresol on losartan metabolism in vitro. The Journal of pharmacy and pharmacology 62(1),133-8頁 （共著）
|
|
23.
|
2010
|
論文
|
Characterization, in vitro cytotoxicity and cellular accumulation of paclitaxel-loaded lipid nano-emulsions. Journal of microencapsulation 27(5),453-9頁 （共著）
|
|
24.
|
2009/06
|
論文
|
Molecular changes to HeLa cells on continuous exposure to SN-38, an active metabolite of irinotecan hydrochloride. Cancer letters 278(1),88-96頁 （共著）
|
|
25.
|
2009/04
|
論文
|
The structure-activity correlation on the inhibitory effects of flavonoids on cytochrome P450 3A activity. Biological & pharmaceutical bulletin 32(4),671-6頁 （共著）
|
|
26.
|
2009
|
論文
|
Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport. Oncology research 17(11-12),527-33頁 （共著）
|
|
27.
|
2009
|
論文
|
Effects of nonsteroidal anti-inflammatory drugs on the expression and function of P-glycoprotein/MDR1 in Caco-2 cells. Drug and chemical toxicology 32(4),332-7頁 （共著）
|
|
28.
|
2008/09
|
論文
|
Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines. Cancer chemotherapy and pharmacology 62(4),577-84頁 （共著）
|
|
29.
|
2008/02
|
論文
|
Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA. The Kobe journal of medical sciences 53(6),355-63頁 （共著）
|
|
30.
|
2008/01
|
論文
|
Effects of Sairei-to on the pharmacokinetics of nifedipine in rats. Phytotherapy research : PTR 22(1),12-7頁 （共著）
|
|
31.
|
2008
|
論文
|
Comparative analysis of cell injury after exposure to antitumor platinum derivatives in kidney tubular epithelial cells. Chemotherapy 54(3),217-23頁 （共著）
|
|
32.
|
2008
|
論文
|
Effects of Agaricus blazei Murill extract on sensitivity to chemotherapeutic agents in HeLa cells and its resistant sublines. Journal of dietary supplements 5(3),283-92頁 （共著）
|
|
33.
|
2008
|
論文
|
Effects of turmeric extract on the pharmacokinetics of nifedipine after a single oral administration in healthy volunteers. Journal of dietary supplements 5(4),401-10頁 （共著）
|
|
34.
|
2007/12
|
論文
|
Oxaliplatin-induced hypersensitivity reaction displaying marked elevation of immunoglobulin E. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 13(4),233-5頁 （共著）
|
|
35.
|
2007/09
|
論文
|
Effects of propolis extract on sensitivity to chemotherapeutic agents in HeLa and resistant sublines. Phytotherapy research : PTR 21(9),841-6頁 （共著）
|
|
36.
|
2006/12
|
論文
|
Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel. Cancer chemotherapy and pharmacology 58(6),785-93頁 （共著）
|
|
37.
|
2006
|
論文
|
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy. Current pharmaceutical design 12(3),273-86頁 （共著）
|
|
38.
|
2005/01
|
論文
|
Effects of 19 herbal extracts on the sensitivity to paclitaxel or 5-fluorouracil in HeLa cells. Biological & pharmaceutical bulletin 28(1),138-42頁 （共著）
|
|
39.
|
2004/12
|
論文
|
Studies on interactions between functional foods or dietary supplements and medicines. III. Effects of ginkgo biloba leaf extract on the pharmacokinetics of nifedipine in rats. Biological & pharmaceutical bulletin 27(12),2042-5頁 （共著）
|
|
40.
|
2004/12
|
論文
|
Studies on interactions between functional foods or dietary supplements and medicines. IV. Effects of ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers. Biological & pharmaceutical bulletin 27(12),2006-9頁 （共著）
|
|
41.
|
2004/10
|
論文
|
Effect of rabeprazole on MDR1-mediated transport of Rhodamine 123 in Caco-2 and Hvr100-6 cells. Biological & pharmaceutical bulletin 27(10),1694-6頁 （共著）
|
|
42.
|
2004/04
|
論文
|
Carvedilol: a new candidate for reversal of MDR1/P-glycoprotein-mediated multidrug resistance. Anti-cancer drugs 15(4),pp.303-9 （共著）
|
|
43.
|
2003/10
|
論文
|
Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAS in small intestine. Drug metabolism and disposition: the biological fate of chemicals 31(10),pp.1235-9 （共著）
|
|
44.
|
2003/06
|
論文
|
Digoxin up-regulates multidrug resistance transporter (MDR1) mRNA and simultaneously down-regulates steroid xenobiotic receptor mRNA. Biochemical and biophysical research communications 306(1),pp.116-20 （共著）
|
|
45.
|
2003/05
|
論文
|
Effects of continuous exposure to digoxin on MDR1 function and expression in Caco-2 cells. The Journal of pharmacy and pharmacology 55(5),pp.675-81 （共著）
|
|
46.
|
2003/02
|
論文
|
Effects of reactive oxygen species on cell proliferation and death in HeLa cells and its MDR1-overexpressing derivative cell line. Biological & pharmaceutical bulletin 26(2),pp.278-81 （共著）
|
|
47.
|
2003/02
|
論文
|
Up-regulation of MDR1 function and expression by cisplatin in LLC-PK1 cells. Biological & pharmaceutical bulletin 26(2),pp.205-9 （共著）
|
|
48.
|
2003/01
|
論文
|
Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil. Cancer science 94(1),pp.81-6 （共著）
|
|
49.
|
2002/12
|
論文
|
MDR1-mediated interaction of digoxin with antiarrhythmic or antianginal drugs. Biological & pharmaceutical bulletin 25(12),pp.1604-7 （共著）
|
|
50.
|
2002/12
|
論文
|
Monocarboxylate transporter mediates uptake of lovastatin acid in rat cultured mesangial cells. Journal of pharmaceutical sciences 91(12),pp.2605-13 （共著）
|
|
51.
|
2002/08
|
論文
|
Effects of 12 Ca2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression. European journal of pharmaceutical sciences 16(3),pp.159-65 （共著）
|
|
52.
|
2002/06
|
論文
|
Cytotoxic effects of 27 anticancer drugs in HeLa and MDR1-overexpressing derivative cell lines. Biological & pharmaceutical bulletin 25(6),pp.771-8 （共著）
|
|
53.
|
2002/03
|
論文
|
Digoxin up-regulates MDR1 in human colon carcinoma Caco-2 cells. Biochemical and biophysical research communications 292(1),pp.190-4 （共著）
|
|
54.
|
2002/03
|
論文
|
Relationships between the in vitro cytotoxicity and transport characteristics of pirarubicin and doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells. Cancer chemotherapy and pharmacology 49(3),pp.244-50 （共著）
|
|
55.
|
2002/03
|
論文
|
Simvastatin and lovastatin, but not pravastatin, interact with MDR1. The Journal of pharmacy and pharmacology 54(3),pp.419-23 （共著）
|
|
56.
|
2002/02
|
論文
|
Interaction of digoxin with antihypertensive drugs via MDR1. Life sciences 70(13),pp.1491-500 （共著）
|
|
57.
|
2002
|
論文
|
Effects of St John's wort and hypericin on cytotoxicity of anticancer drugs. Drug metabolism and pharmacokinetics 17(5),467-74頁 （共著）
|
|
5件表示
|
|
全件表示(57件)
|
